AU9678501A - Pharmaceutical solutions of modafinil compounds - Google Patents

Pharmaceutical solutions of modafinil compounds

Info

Publication number
AU9678501A
AU9678501A AU9678501A AU9678501A AU9678501A AU 9678501 A AU9678501 A AU 9678501A AU 9678501 A AU9678501 A AU 9678501A AU 9678501 A AU9678501 A AU 9678501A AU 9678501 A AU9678501 A AU 9678501A
Authority
AU
Australia
Prior art keywords
modafinil compounds
pharmaceutical solutions
modafinil
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU9678501A
Other languages
English (en)
Inventor
Martin J Jacobs
Bradley T Mcintyre
Piyush R Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon LLC
Original Assignee
Cephalon LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon LLC filed Critical Cephalon LLC
Publication of AU9678501A publication Critical patent/AU9678501A/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU9678501A 2000-10-11 2001-10-11 Pharmaceutical solutions of modafinil compounds Pending AU9678501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23948800P 2000-10-11 2000-10-11
US09/974,473 US6489363B2 (en) 2000-10-11 2001-10-10 Pharmaceutical solutions of modafinil compounds
PCT/US2001/031685 WO2002030413A1 (en) 2000-10-11 2001-10-11 Pharmaceutical solutions of modafinil compounds

Publications (1)

Publication Number Publication Date
AU9678501A true AU9678501A (en) 2002-04-22

Family

ID=26932612

Family Applications (2)

Application Number Title Priority Date Filing Date
AU9678501A Pending AU9678501A (en) 2000-10-11 2001-10-11 Pharmaceutical solutions of modafinil compounds
AU2001296785A Ceased AU2001296785B2 (en) 2000-10-11 2001-10-11 Pharmaceutical solutions of modafinil compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001296785A Ceased AU2001296785B2 (en) 2000-10-11 2001-10-11 Pharmaceutical solutions of modafinil compounds

Country Status (21)

Country Link
US (1) US6489363B2 (enExample)
EP (1) EP1324755B1 (enExample)
JP (1) JP2004510816A (enExample)
KR (1) KR100846914B1 (enExample)
CN (1) CN100518726C (enExample)
AT (1) ATE478662T1 (enExample)
AU (2) AU9678501A (enExample)
BG (1) BG66221B1 (enExample)
BR (1) BR0114813A (enExample)
CA (1) CA2425218C (enExample)
CZ (1) CZ2003966A3 (enExample)
DE (1) DE60142913D1 (enExample)
EA (1) EA005572B1 (enExample)
HU (1) HU229424B1 (enExample)
IL (2) IL155263A0 (enExample)
MX (1) MXPA03003150A (enExample)
NO (1) NO333096B1 (enExample)
NZ (1) NZ525166A (enExample)
PL (1) PL214879B1 (enExample)
SK (1) SK287436B6 (enExample)
WO (1) WO2002030413A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919378B2 (en) * 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
KR100911952B1 (ko) * 2000-10-11 2009-08-13 세파론, 인코포레이티드 모다피닐 화합물을 포함하는 조성물
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
FR2849029B1 (fr) 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
WO2004082624A2 (en) * 2003-03-17 2004-09-30 Neurohealing Pharmaceuticals, Inc. Modafinil-based neurorehabilitation of impaired neurological function associated with injury
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US8153159B2 (en) * 2003-09-18 2012-04-10 Cephalon, Inc. Modafinil modified release pharmaceutical compositions
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
BRPI0500520A (pt) * 2005-02-16 2006-09-26 Henry Jun Suzuki uso de agentes flavorizantes aromáticos de alto ponto de fusão como agentes solubilizantes ou inibidores de cristalização em composições farmacêuticas
US20090123545A1 (en) * 2005-07-21 2009-05-14 Ron Eyal S Rapid Onset and Short Term Modafinil Compositions and Methods of Use Thereof
WO2008021341A2 (en) 2006-08-14 2008-02-21 Neurohealing Pharmaceuticals, Inc. Modafinil-based treatment for premature ejaculation
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil
CA2629979A1 (en) * 2008-04-25 2009-10-25 Pharmascience Inc. Novel resveratrol compositions
FR2987266B1 (fr) 2012-02-28 2014-12-19 Debregeas Et Associes Pharma Procede d'obtention d'une composition pharmaceutique a base de modafinil, composition pharmaceutique ainsi obtenue et son application
FR2987265B1 (fr) 2012-02-28 2014-02-28 Debregeas Et Associes Pharma Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application
MX2015004973A (es) * 2012-10-18 2015-07-17 Abbvie Inc Formulaciones de compuestos derivados de pirimidindiona.
US9616068B2 (en) 2014-10-27 2017-04-11 Pohela LLC Animal training using cognitive enhancement

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2663225B1 (fr) 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
FR2771004B1 (fr) 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
US6200968B1 (en) 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US20010034373A1 (en) 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function

Also Published As

Publication number Publication date
ATE478662T1 (de) 2010-09-15
AU2001296785B2 (en) 2006-03-16
BG107720A (bg) 2004-01-30
HUP0302478A3 (en) 2005-05-30
HU229424B1 (hu) 2013-12-30
IL155263A (en) 2007-07-24
NO20031648L (no) 2003-06-04
NZ525166A (en) 2006-10-27
HUP0302478A2 (hu) 2003-11-28
BR0114813A (pt) 2005-01-25
US6489363B2 (en) 2002-12-03
CZ2003966A3 (cs) 2003-09-17
SK287436B6 (sk) 2010-09-07
PL214879B1 (pl) 2013-09-30
SK4402003A3 (en) 2003-09-11
EA005572B1 (ru) 2005-04-28
MXPA03003150A (es) 2003-07-14
US20020099097A1 (en) 2002-07-25
DE60142913D1 (de) 2010-10-07
HK1057336A1 (en) 2004-04-02
PL361134A1 (en) 2004-09-20
CN1468096A (zh) 2004-01-14
CA2425218A1 (en) 2002-04-18
KR20030055279A (ko) 2003-07-02
NO333096B1 (no) 2013-03-04
EP1324755A1 (en) 2003-07-09
EP1324755B1 (en) 2010-08-25
CN100518726C (zh) 2009-07-29
CA2425218C (en) 2010-10-05
NO20031648D0 (no) 2003-04-10
JP2004510816A (ja) 2004-04-08
KR100846914B1 (ko) 2008-07-17
BG66221B1 (bg) 2012-06-29
EA200300450A1 (ru) 2003-08-28
IL155263A0 (en) 2003-11-23
WO2002030413A1 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
AU9678501A (en) Pharmaceutical solutions of modafinil compounds
MXPA05004697A (es) Soluciones farmaceuticas que comprenden un compuesto modafinil y uso para la fabricacion de un medicamento para tratar diferentes enfermedades.
WO2004006858A3 (en) Compounds, compositions, and methods employing same
AP2003002755A0 (en) Guanidinobenzamides as mc4-r agonists
MXPA03007140A (es) Derivados de carbolina.
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
ATE231872T1 (de) Thiazolopyrimidinderivate
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
YU87202A (sh) Derivati arilmetilamina koji se koriste kao inhibitori triptaze
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
WO2003066597A3 (en) Guanidino compounds
DE60223576D1 (de) Hautbehandlungszusammensetzung
ZA200210316B (en) Composition and its therapeutic use.
SE0001916D0 (sv) Novel formulation
DK1537132T3 (da) Salt af mortin-6-glucuronid
GB0326221D0 (en) Therapeutic agents,compositions,preparations and uses
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
WO2003080568A3 (en) Probucol derivatives
MXPA02003731A (es) Derivados novedosos de acido fusidico.
DE50211461D1 (de) Pharmazeutische zusammensetzung enthaltend bulbophyllum
EP1417968A3 (en) Antitumour compositions containing propolis and resveratrol
WO2000050023A3 (en) Use of tamoxifen and related compounds as CLC3 blockers in the treatment of vascular diseases
HK1087923A (en) Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases
ATE247976T1 (de) 10-formyltetrahydrofolate dehydrogenase als therapeutischen mittel